Comment
doi: 10.1093/sleep/32.11.1407.
Rebound hypersomnolence, stimulant abuse, and DAT-mediated dopamine release
Affiliations
- PMID: 19928377
- PMCID: PMC2768944
- DOI: 10.1093/sleep/32.11.1407
Item in Clipboard
Comment
Rebound hypersomnolence, stimulant abuse, and DAT-mediated dopamine release
Sleep.
2009 Nov.
No abstract available
Comment on
-
The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.Sleep. 2009 Nov;32(11):1425-38. doi: 10.1093/sleep/32.11.1425. Sleep. 2009. PMID: 19928382 Free PMC article.
Similar articles
-
The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.Sleep. 2009 Nov;32(11):1425-38. doi: 10.1093/sleep/32.11.1425. Sleep. 2009. PMID: 19928382 Free PMC article.
-
Molecular Mechanisms of Amphetamines.Handb Exp Pharmacol. 2020;258:265-297. doi: 10.1007/164_2019_251. Handb Exp Pharmacol. 2020. PMID: 31286212 Review.
-
Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats.J Pharmacol Exp Ther. 2011 May;337(2):380-90. doi: 10.1124/jpet.111.178947. Epub 2011 Feb 7. J Pharmacol Exp Ther. 2011. PMID: 21300706
-
Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat.J Sleep Res. 2000 Mar;9(1):89-96. doi: 10.1046/j.1365-2869.2000.00181.x. J Sleep Res. 2000. PMID: 10733694
-
Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine.Neuropharmacology. 2014 Dec;87:19-40. doi: 10.1016/j.neuropharm.2014.06.012. Epub 2014 Jun 19. Neuropharmacology. 2014. PMID: 24953830 Review.
Cited by
-
Sedation After a Trial of Mixed Amphetamine Salts in a Boy with Attention-Deficit/Hyperactivity Disorder.Am J Case Rep. 2020 Dec 17;21:e928269. doi: 10.12659/AJCR.928269. Am J Case Rep. 2020. PMID: 33328428 Free PMC article.
References
-
- Miller JD, Farber J, Gatz P, Roffwarg H, German DC. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat. Brain Res. 1983;273:133–41. - PubMed
-
- Nishino S, Mignot E. CNS stimulants in sleep medicine: basic mechanisms and pharmacology. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4th ed. Philadelphia: Elsevier Saunders; 2005. pp. 468–98.
-
- Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. J Biol Chem. 2003;278:12070–7. - PubMed
-
- Segal DS, Kuczenski R. Behavioral pharmacology of amphetamine. In: Cho AK, Segal DS, editors. Amphetamine and its analogs: psychopharmacology, toxicology and abuse. San Diego: Academic Press; 1994. pp. 115–50.
